Hysterectomy News and Research

Latest Hysterectomy News and Research

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

Cumberland Pharmaceuticals Inc. today announced the publication of data affirming the safety and efficacy of Caldolor® (ibuprofen) Injection in treating post-operative pain in hospitalized patients. A Phase III study published in the peer-reviewed journal Pain Practice concluded that IV ibuprofen significantly reduced both morphine use and self-reported pain intensity in patients recovering from abdominal hysterectomy compared to morphine alone.

27 Jan 2011

Initiative to eliminate cervical cancer in North Carolina

Patricia Gregory of Cary was only 24 years old when she was diagnosed with cervical cancer. Now a mother of an 11-year-old daughter, she considers herself blessed to have a child, as cervical cancer can make women unable to bear children.

21 Jan 2011

MMA calls for delay in release of Medica's physician rating program

The Minnesota Medical Association has asked Medica to delay the January 19 scheduled public release date of their individual physician rating program, known as the Premium Designation Program.

19 Jan 2011

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Women suffering from uterine fibroids, a debilitating condition that affects more than seven million women in the U.S., may soon have reason for hope. Halt Medical, a biomedical company based in the San Francisco Bay Area, is developing a minimally invasive procedure for treating the condition. The company recently presented their findings from studies in Latin America at the NIH Global Fibroid Congress.

21 Dec 2010

Washington State Hospital Association makes public surgical infection rates

Today, the Washington State Hospital Association is releasing hospital-specific surgical infection rate data. This is the first time this information has been made public.

1 Dec 2010

AAGL recommends vaginal or laparoscopic hysterectomies

Approximately 600,000 hysterectomies are performed in the United States annually to treat benign disorders of the pelvis. More than two-thirds are performed through an abdominal incision. In an evidence-based position statement published online today in The Journal of Minimally Invasive Gynecology, the AAGL, a medical specialty society of over 5,000 gynecologic surgeons, advocates the practice of performing these procedures vaginally or laparoscopically in a minimally invasive manner, thus reducing morbidity and facilitating a faster recovery period.

8 Nov 2010

African Americans more likely to have uterine cancer recurrence

African Americans are more likely to have a recurrence of uterine cancer despite undergoing a total hysterectomy or a hysterectomy followed by radiation therapy, according to researchers at Henry Ford Hospital in Detroit.

2 Nov 2010

Estrogen therapy increases risk of kidney stone development in postmenopausal women

Use of estrogen therapy is associated with an increased risk of developing kidney stones in postmenopausal women, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Oct 2010

Intrauterine devices for treatment of endometrial cancer

Intrauterine devices, originally developed as contraceptives, can also be used to treat and cure cancer of the endometrium according to new research published online in the cancer journal, Annals of Oncology today (Wednesday 29 September). The finding opens the way for young women with the disease, which affects the lining of the womb, to be treated without the need for a hysterectomy, thus preserving their fertility until they have had all the children they want.

29 Sep 2010

Cook Medical invites experts to discuss postpartum hemorrhage

Cook Medical has invited experts in women's health and postpartum hemorrhage from North America, Europe, Middle East and Africa to participate in a roundtable discussion with the world press to explore the causes, risk factors and prevalence of postpartum hemorrhage (PPH) a fatal complication of childbirth that affects approximately 14 million women annually.

21 Sep 2010

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC Cancer Agency have begun an important campaign that will reduce deaths from ovarian cancer.

9 Sep 2010

New Halt System procedure for non-cancerous fibroid treatment

A new device manufactured by Northern California-based Halt Medical recently received FDA 510K clearance using a radio-frequency energy system to treat soft tissues. Fully qualified doctors insert the Halt System into targeted fibroids under ultrasound guidance. This procedure targets the core of the fibroid, by cauterizing the blood flow that feeds the fibroid, which decreases fibroid size and subsequent discomfort.

24 Aug 2010

Use of estrogen alone does not increase lung cancer mortality in postmenopausal women: Study

Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online August 13 in The Journal of the National Cancer Institute. In the Women's Health Initiative (WHI) trial, which consisted of several clinical trials on postmenopausal women, one study showed women with previous hysterectomy taking combined estrogen plus progestin therapy had a statistically significant increase in lung cancer mortality, but not incidence. Other studies with combined hormone therapy have had conflicting results. But the influence of estrogen alone was unclear.

16 Aug 2010

Clinicians in rural hospitals demonstrate high standard of care to patients: Study

Smaller, rural hospitals may be quicker and more efficient at implementing surgical safety initiatives than their larger, urban counterparts, and are capable of providing a standard of surgical care that is at par with major hospitals that provide a comprehensive array of care services, according to an 18-month series of studies led by researchers from the University of Louisville Department of Surgery.

28 Jul 2010

Cara Therapeutics closes Series D financing of $15 million

Cara Therapeutics, Inc. announced today that it had closed on a Series D financing of $15 million. The round was led by new investor, Rho Ventures, with participation from previous investors Alta Biopharma, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Healthcare Private Equity, Mitsubishi International Corporation and MVM Life Science Partners.

21 Jul 2010

Texas Health Presbyterian Hospital Dallas named Center of Excellence for gynecological surgery

Texas Health Presbyterian Hospital Dallas is the first hospital in Texas — and one of only three in the United States — to be named a Center of Excellence for gynecological surgery by the American Institute for Minimally Invasive Surgery.

9 Jul 2010

Simbionix, USF Health receive BIRD Grant for development of Laparoscopic Hysterectomy simulation module

Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, and USF Health, an organization dedicated to creating a model of health care based on understanding the full spectrum of health, are proud to announce that together they received a BIRD (Binational Industrial Research and Development) Grant to support the development of a Laparoscopic Hysterectomy simulation module.

1 Jul 2010

UPA: An effective non-invasive treatment for fibroids can help maintain fertility in women

A new, effective, non-surgical treatment for uterine fibroids can help women with this condition maintain their fertility, an American scientist told the 26th annual meeting of the European Society of Human Reproduction and Embryology in Rome today (Wednesday).

30 Jun 2010

Methodist surgeons study transvaginal removal of donor kidney

Surgeons at The Methodist Hospital in Houston are studying a new way to make kidney donation safer, less invasive and almost scar free for women by using a new technique that removes kidneys transvaginally.

22 Jun 2010

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.

17 Jun 2010

Hysterectomy News and Research

Latest Hysterectomy News and Research

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

Initiative to eliminate cervical cancer in North Carolina

MMA calls for delay in release of Medica's physician rating program

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Washington State Hospital Association makes public surgical infection rates

AAGL recommends vaginal or laparoscopic hysterectomies

African Americans more likely to have uterine cancer recurrence

Estrogen therapy increases risk of kidney stone development in postmenopausal women

Intrauterine devices for treatment of endometrial cancer

Cook Medical invites experts to discuss postpartum hemorrhage

BC gynecologists initiate campaign to reduce ovarian cancer mortality

New Halt System procedure for non-cancerous fibroid treatment

Use of estrogen alone does not increase lung cancer mortality in postmenopausal women: Study

Clinicians in rural hospitals demonstrate high standard of care to patients: Study

Cara Therapeutics closes Series D financing of $15 million

Texas Health Presbyterian Hospital Dallas named Center of Excellence for gynecological surgery

Simbionix, USF Health receive BIRD Grant for development of Laparoscopic Hysterectomy simulation module

UPA: An effective non-invasive treatment for fibroids can help maintain fertility in women

Methodist surgeons study transvaginal removal of donor kidney

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Hysterectomy News and Research

Latest Hysterectomy News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in